Skip to content
Wenlo
Sign in
← Markets
Market closed · Opens 4:00 AM ET

BDX Becton, Dickinson and Company

NYSE
$198.60+$0.72 (+0.36%)

At close Mon, Nov 2

Loading chart…

Open
$197.52
Previous close
$197.88
Day range
197.23 – 199.92
52-week range
127.59 – 200.47
Volume
1.8M
Avg volume (3M)
1.7M
Market cap
$54B
P/E (TTM)
45.33
EPS (TTM)
$4.30
Beta
0.28
Dividend yield
2.12%
Next earnings
—
Ex-dividend
Sep 9, 2026
Sector
Healthcare

About Becton, Dickinson and Company

Becton, Dickinson and Company is a global medical technology company that develops, manufactures, and sells a broad range of products used across healthcare and life sciences. Becton, Dickinson and Company serves hospitals, physicians, clinical laboratories, researchers, and public health organizations with medical supplies, diagnostic systems, laboratory equipment, and interventional devices. Its current business centers on medical essentials, connected care, biopharma systems, and interventional products, supporting workflows such as specimen handling, medication delivery, infection prevention, vascular access, and surgical procedures. The company’s portfolio also includes tools and technologies used in drug delivery, patient safety, and clinical research. Headquartered in Franklin Lakes, New Jersey, Becton, Dickinson and Company plays an important role in enabling medical discovery, improving care delivery, and supporting routine operations in healthcare settings worldwide.

BDX news and filings

Loading filings…

Filings from SEC EDGAR.